急性出血和缺血性脑卒中高血压控制的研究进展  

Management of Hypertension in Acute Ischemic and Hemorrhagic Stroke

作　　者：赵宁军[1] 李维根[1] 耿德勤[1] 

机构地区：[1]江苏省徐州医学院附属医院,221002

出　　处：《中国临床神经科学》2011年第4期408-414,共7页Chinese Journal of Clinical Neurosciences

摘　　要：从长期来看,高血压病患者的降压治疗可以显著降低出血性和缺血性脑卒中的发生和复发。对于蛛网膜下腔出血、脑出血或急性缺血性脑卒中的患者,在发病后的急性期,血压控制的最佳目标血压水平是不确定的。关于脑卒中后立即行血压控制的最佳血压水平的临床试验证据是有限和有争议的。脑卒中患者的血压控制主要是依据普通人群血压控制的指南,辅以基于小样本病例研究的专家建议。脑卒中是一种异质性疾病,适当的血压控制,其效果因不同类型脑卒中的发病机制不同而异。Long-term antihypertensive therapy is associated with significant reduction in the incident and recurrent ischemic and hemorrhagic stroke.It is uncertain for optimal blood pressure（BP） target in patients with acute subarachnoid hemorrhage（SAH）,intracerebral hemorrhage（ICH） and acute ischemic stroke（AIS）.Evidence from clinical trials for optimal management of BP immediately after stroke is limited and controversial.BP management in stroke patients is mainly based on guidelines for BP management in the general population,supplemented by expert opinion.Stroke is a heterogeneous disease,appropriate management of BP may be different according to the subtype of stroke and its mechanism.

关 键 词：脑卒中 血压 控制 

分 类 号：R743[医药卫生—神经病学与精神病学] R544.1[医药卫生—临床医学]